INSIGHTS ON DRUG DEVELOPMENT
-
Integration From Formulation Development To Manufacturing, Packaging
Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.
-
Ask Us Anything: Erik Feldmann On Advancing Peptide Development
Erik Feldmann, Technical Director, on the analytical challenges of proteins, peptides, and oligonucleotides — and why he starts every method-development problem by understanding what the customer is trying to achieve.
-
Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics
Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.
-
Is Lipinski's Rule Of Five Still Relevant In Drug Development?
Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.
-
Injection Site Reaction Screening Methodology6/6/2025
Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.
-
Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration8/20/2025
Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.
-
Characterization Of Pharmaceutical Materials With Modulated DSC12/30/2024
Modulated DSC addresses challenges in pharmaceutical material characterization, enabling precise analysis of glass transitions, and overlapping transitions, enhancing insights beyond standard DSC.
-
Advances In Custom Medium Development: The Multi-Omics Difference6/9/2025
Spent media analysis continues to be an essential part of many media development workflows. Newer techniques, however, using state-of-the-art analytical technology, are becoming more popular.
-
ADC Development Grows More Complex — SPR Insights Bring Clarity4/14/2026
Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
DRUG DEVELOPMENT SOLUTIONS
-
End-to-end pharma manufacturing support unites development expertise and scalable production to accelerate the path from formulation to commercial supply with quality and flexibility.
-
Overcome shared lab challenges with the Avanti JXN-30 high-speed centrifuge
- 4.0 L Max Capacity
- 30,000 RPM
- 110,510 x g
-
Leica M125 C Encoded Stereo Microscopes
Total recall of your settings
Your goal: high-quality images that allow measurements and can be accurately repeated with minimal effort. The Leica coded stereo microscopes help you to pave the way to correct results.
- Coded microscopes consistently deliver calibrated and comparable images
- Reproduce images in moments with the Leica “Store and Recall” function
- Fully apochromatic corrected zoom optics deliver high quality images
- Customize the microscope system to your task with the exclusive range of accessories
-
Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.
-
Our HPAPI development and manufacturing spans preclinical through commercial supply across 13 global sites, with SafeBridge-certified containment and 30 years of cytotoxic compound expertise.